Recent Updates
Recently added Catalysts
HCM Neutral Sentiment Score: 60/100

Blocklisting Six Monthly Return Hong Kong, Shanghai, & Florham Park, NJ - Monday

Key Takeaway: HUTCHMED (China) Limited has released its blocklisting six monthly return as of June 30, 2025. The company outlined details of its 2015 Share Option Scheme, noting a balance of 45,992,018 ordinary shares left under the scheme at the end of the reporting period. Additionally, 510,375 securities were issued during this timeframe. The total ordinary shares in issue now stand at 872,111,470.

Market Sentiment Analysis

Full Press Release Details

Blocklisting Six Monthly Return
Hong Kong, Shanghai, & Florham Park, NJ - Monday, June 30, 2025: HUTCHMED (China) Limited ("HUTCHMED" or the "Company") (Nasdaq/AIM: HCM; HKEX: 13) announces the following blocklisting six monthly return:
1. Name of applicant: HUTCHMED (China) Limited
2. Name of scheme: Share Option Scheme conditionally adopted by HUTCHMED in 2015 ("2015 HUTCHMED Share Option Scheme")
3. Period of return: From December 29, 2024 to June 28, 2025
4. Balance under scheme from previous return: 2015 HUTCHMED Share Option Scheme: 46,502,393 ordinary shares of US$0.1 each
5. The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return: 2015 HUTCHMED Share Option Scheme: Nil
6. Number of securities issued/allotted under scheme during period: 2015 HUTCHMED Share Option Scheme: 510,375
7. Balance under scheme not yet issued/allotted at end of the period: 2015 HUTCHMED Share Option Scheme: 45,992,018 ordinary shares of US$0.1 each
8. Number and class of securities originally listed and the date of admission: 25,198,880 ordinary shares of US$0.1 each admitted on June 17, 2019 ( to replace the Company's previous block admission schemes following the Company's share subdivision which took effect on May 30, 2019)
9. Total number of securities in issue at the end of the period: 872,111,470 ordinary shares of US$0.1 each
Name of contact: Weiguo Su
Address of contact: Level 18, The Metropolis Tower, 10 Metropolis Drive, Hung Hom, Kowloon, Hong Kong
Telephone number of contact: +852 2121 8200
Investor Enquiries +852 2121 8200 / ir@hutch-med.com
Media Enquiries
FTI Consulting - +44 20 3727 1030 / HUTCHMED@fticonsulting.com
Ben Atwell / Alex Shaw +44 7771 913 902 (Mobile) / +44 7779 545 055 (Mobile)
Brunswick - Zhou Yi +852 9783 6894 (Mobile) / HUTCHMED@brunswickgroup.com
Panmure Liberum Nominated Advisor and Joint Broker
Atholl Tweedie / Emma Earl / Rupert Dearden +44 20 7886 2500
HSBC Joint Broker
Simon Alexander / Alina Vaskina / Arnav Kapoor +44 20 7991 8888
Cavendish Joint Broker
Geoff Nash / Nigel Birks +44 20 7220 0500

Frequently Asked Questions

What is the name of the applicant in the blocklisting return?

The applicant is HUTCHMED (China) Limited.

How many shares were allotted under the 2015 scheme recently?

A total of 510,375 shares were issued under the scheme.

What is the balance of shares remaining under the scheme?

The balance not yet allotted is 45,992,018 shares.

When was the 2015 Share Option Scheme adopted?

The scheme was conditionally adopted in 2015.

What is the total number of securities in issue at period's end?

The total number of securities in issue is 872,111,470.

Last updated: Jun 30, 2025